罗娇，女，1990年10月生，安徽宿州人。2018年6月毕业于中国科学院海洋研究所，海洋生物学博士。现为青岛大学公共卫生学院助理教授，青年卓越人才，硕士生导师。
一、主要研究方向
1. 酒精性肝损伤的毒作用机制及干预研究（表观遗传学及蛋白质修饰方向）；
2. 基于单细胞转录组的酒精肝数据挖掘及分子机制研究；
二、代表性科研成果
1）近5年学术论文（一作/共同一作）
1. Chen, N. #, Luo, J. #, Hou, Y. #, Ji, Y., Xie, M., Song, G., & Yu, D. * (2022). miR-29c-3p promotes alcohol dehydrogenase gene cluster expression by activating an ADH6 enhancer. Biochemical Pharmacology, 203, 115182. (IF:6.1)
2. Luo, J.#, Hou, Y. #, Ma, W., Xie, M., Jin, Y., Xu, L., ... & Yu, D.* (2021). A novel mechanism underlying alcohol dehydrogenase expression: hsa-miR-148a-3p promotes ADH4 expression via an AGO1-dependent manner in control and ethanol-exposed hepatic cells. Biochemical Pharmacology, 189, 114458. (IF: 6.1)
3. Luo, J. #, Xie, M.#, Hou, Y., Ma, W., Jin, Y., Chen, J., ... & Yu, D.* (2021). A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease. Biochemical Pharmacology, 188, 114582. (IF: 6.1)
4. Jiang, B. #, Luo, J. #, Guo, S., & Wang, L. * (2021). Discovery of 5-(3-bromo-2-(2, 3-dibromo-4, 5-dimethoxybenzyl)-4, 5-dimethoxybenzylidene) thiazolidine-2, 4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties. Bioorganic Chemistry, 108, 104648. (IF: 5.3)
5. Luo, J., Zheng, M., Jiang, B., Li, C., Guo, S., Wang, L., ... & Shi, D.* (2020). Antidiabetic activity in vitro and in vivo of BDB, a selective inhibitor of protein tyrosine phosphatase 1B, from Rhodomela confervoides. British Journal of Pharmacology, 177(19), 4464-4480. (IF: 9.5)
6. Luo, J., Zhang, R., Wang, X., Hou, Z., Guo, S., & Jiang, B.* (2020). Binding properties of marine bromophenols with human protein tyrosine phosphatase 1B: Molecular docking, surface plasmon resonance and cellular insulin resistance study. International Journal of Biological Macromolecules, 163, 200-208. (IF: 8.0)
7. Luo, J., Jiang, B., Li, C., Jia, X., & Shi, D.* (2019). CYC27 synthetic derivative of bromophenol from red alga Rhodomela confervoides: anti-diabetic effects of sensitizing insulin signaling pathways and modulating RNA splicing-associated RBPs. Marine drugs, 17(1), 49. (IF: 6.1)
8. Ma, X.#, Zhang, X.#, Luo, J.#, Liang, B., Peng, J., Chen, C., ... & Xiao, Y.* (2020). MiR-486-5p-directed MAGI1/Rap1/RASSF5 signaling pathway contributes to hydroquinone-induced inhibition of erythroid differentiation in K562 cells. Toxicology in Vitro, 66, 104830. (IF: 3.7)
9. Luo, J., Xu, Q., Jiang, B., Zhang, R., Jia, X., Li, X., ... & Shi, D.* (2018). Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor. British journal of pharmacology, 175(1), 140-153. (IF: 9.5)
2）发明专利
1．于典科，罗娇，赵艳洁，靳远，郑玉新；用于检测甲基化对miRNA和mRNA结合影响的方法；申请号：201910449084.X。
三、主要科研项目
1. 国家自然科学基金委员会，面上项目，82273670，基于单细胞转录组研究肝窦内皮细胞JAM2高表达致酒精肝相关免疫细胞跨内皮迁移浸润的作用机制，2023-01至2026-12，52万元，在研，主持；
2. 国家自然科学基金委员会，青年项目，81903354，miR-29c通过非经典模式调控酒精性肝损伤的作用机制研究，2020-01至2022-12，21万元，在研，主持；
3. 中国博士后基金会，面上项目，2020M672008，miR-214通过非经典模式调控酒精性肝损伤的作用机制研究，2020-01至2021-12，8万元，已结题，主持；
联系方式
E-mail：luojiao2012@163.com（常用邮箱）或luojiao@qdu.edu.cn
